Ensysce Biosciences, Inc. (ENSC) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ensysce Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:03.632 Good morning and welcome to the NCIS Biosciences, Inc. 00:00:03.632 -- 00:00:08.496 Corporate Update Call. As a reminder, this conference call is being recorded. 00:00:08.496 -- 00:00:13.039 Your hosts today are Dr. Lynn Kirkpatrick, Chief Executive Officer, Dr. 00:00:13.039 -- 00:00:18.604 Bill Smith, Chief Medical Officer, and Dave Humphrey, Chief Financial Officer. 00:00:18.604 -- 00:00:22.747 Before we begin the phone presentation, I would like to remind everyone that the statements 00:00:22.747 -- 00:00:27.310 made on the call and webcast may include predictions, estimates, or other information 00:00:27.310 -- 00:00:30.325 that might be considered forward-looking 00:00:30.325 -- 00:00:34.086 While these forward-looking statements represent our current judgment on what the future 00:00:34.086 -- 00:00:38.468 holds, they are subject to risks and uncertainties that could cause actual results to 00:00:38.468 -- 00:00:43.069 differ materially. We are cautioned not to place undue reliance on these forward-looking 00:00:43.069 -- 00:00:47.871 statements, which reflect our opinions only as of the date of this presentation. 00:00:47.871 -- 00:00:52.032 Please keep in mind that we are not obligating ourselves to revise or publicly release 00:00:52.032 -- 00:00:56.094 the results of any revision to these forward-looking statements in light of new information 00:00:56.094 -- 00:01:00.258 or future events. Throughout today's discussion, we will attempt to present some important 00:01:00.258 -- 00:01:03.981 factors relating to our business that may affect our predictions. 00:01:03.981 -- 00:01:08.803 You should also review our most recent forms, 10Q and 10K, for a more complete discussion 00:01:08.803 -- 00:01:14.046 of these factors and ot...